doi: 10.1006/bbrc.1995.1715 51 LinJMastNBedermanILiYBrunengraberHBjrkhemIet al
M., et al., Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes (SURMOUNT2): A DoubleBlind, Randomised, Multicentre, PlaceboControlled, Phase 3 Trial, Lancet 402, no
It has been approved by the U.S
Decisions around nutrition and medication management, sweeteners, and dietary fat should follow ADA guidance, especially for people with insulin resistance or cardiovascular risk
People using tirzepatide for weight management alone may experience a slower metabolic shift by comparison
Your Wellness Journey Starts Here Connect with our expert clinicians to discuss your needs and discover how Dallas Therapy Alliance can help you achieve lasting mental wellness.